-
Roy ZHENG
Non-equity Partner / Shanghai
-
Tel +86-21-6061-3653
Email zhengzekun@zhonglun.com
-
Practices
Private Equity & Investment Funds, Hong Kong & Overseas Capital Markets, Investment/M&A & Corporate Governance
-
Industries
Financial Innovation & Fintech, Information & Intelligence Technology, Pharmaceuticals & Life Sciences, Media-Sports & Entertainment
Roy ZHENG
Roy Zheng focuses on the legal practices of private equity/venture capital investment, overseas capital market, corporate financing and structuring, and M&A, primarily in the fields of TMT, biotech and healthcare, media and entertainment, fintech and high-end manufacturing, etc. Mr. Zheng holds PRC bar and New York State bar.
Mr. Zheng is recognized by The Legal 500 Asia Pacific as “Rising Stars” in capital market since 2021 and recommended as “Key Lawyers” since 2020. Per Legal 500’s remarks, “Roy Zheng is dual-qualified in New York and China, making him an ideal person to advise Chinese companies looking to list overseas” and “Roy Zheng is developing a strong overseas capital markets practice, with a focus on the TMT and healthcare sectors.”
Representative Matters
Private Equity & Investment Funds
Represented Geely’s Farizon Auto on its series pre-A financing, red-chip restructuring and share incentive plan
Acted as Blackstone’s PRC legal counsel in its acquisition of Interplex
Acted as Bain Capital’s PRC legal counsel in its investment to Youran Diary in form of convertible note
Acted as PRC legal counsel for BC European Capital X in its sale of CeramTec
Represented Warburg Pincus and Vertex in their respective investment to Mobike
Represented China Taiping in its investment to JD Finance
Represented China’s Social Security Fund (SSF) in its investment to Ant Financial Group
Represented Khazanah Nasional Berhadin its investment to Cainiao Network
Represented CRCI on its investment to Dida Pinche
Hong Kong & Overseas Capital Markets
Acted as the joint bookrunners’ PRC legal advisor in Lufax’s IPO on NYSE
Acted as the issuer’s PRC legal advisor in Zai Lab’s IPO on Nasdaq as well as follow-on offerings, and secondary listing in Hong Kong
Acted as the issuer’s PRC legal advisor in Tongcheng-Elong’s IPO in Hong Kong
Acted as the issuer’s PRC legal advisor in Noah Holding’s secondary listing in Hong Kong
Acted as the issuer’s PRC legal advisor in Qeeka’s IPO in Hong Kong
Acted as the issuer’s PRC legal advisor in OcuMension’s IPO in Hong Kong
Acted as the issuer’s PRC legal advisor in Everest Medicines’ IPO in Hong Kong
Acted as the issuer’s PRC legal advisor in Transcenta’s IPO in Hong Kong
Acted as the joint sponsor’s PRC legal advisor in CARsgen Therapeutics’ IPO in Hong Kong
Acted as the issuer’s PRC legal advisor in LianBio’s IPO on Nasdaq
Acted as the joint bookrunners’ PRC legal advisor in Gracell Biotechnologies’ IPO on Nasdaq
Acted as the issuer’s PRC legal advisor in Anpac’s IPO on Nasdaq
M&A
Represented Tongcheng Network in its merger with E-Dragon, and Tencent’s strategic investment to the post-merger group
Honors and Awards
For Individual
Rising Stars(capital market), The Legal 500 Asia Pacific, 2021, 2022
Key Lawyer, The Legal 500 Asia Pacific, 2020 & 2021 & 2022
For Deal
Deals of the Year(Lufax’s IPO on NYSE), China Business Law Journal, 2020
Deals of the Year(Lufax’s IPO on NYSE), IFLR1000 China Awards, 2021
Editor’s Choice Impact Deal and Case Awards of asialaw Profiles, asialaw Awards, 2021
Equity Securities Deal of the Yea(rLianBio’s IPO on Nasdaq), China Law & Practice Awards, 2022
Related
-
Deals Related
-
Awards Related
Nine Practice Areas and 46 Lawyers from Zhong Lun Made to IFLR1000 2024 Rankings
Nine Practice Areas and 46 Lawyers from Zhong Lun are recommended.
2024-08-23
-
Bar Admissions/Professional Qualifications
Lawyer’s License of People’s Republic of China
New York State Bar -
Education
LL.M., The University of Texas at Austin, School of Law
LL.B., China University of Political Science and Law, School of Law -
Professional Experience
Associate & non-equity partne, Zhong Lun Law Firm
-
Languages
Chinese
English